FDA Inspection 1193038 — Hetero Labs Ltd. - Unit IX

Hetero Labs Ltd. - Unit IX — FEI 3009093782

The FDA completed an inspection of Hetero Labs Ltd. - Unit IX on November 8, 2022 in Visakhapatnam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 8, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Visakhapatnam (India)